Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 4Gastrointestinal 3Other solid neoplasm 1Other neoplasm 1Lymphoid 1

Conditions

Advanced Malignant Neoplasm 1

Interventions

Gemcitabine 2Aminolevulinic Acid 2toripalimab 1tirbanibulin 1ruxolitinib 1potassium oxonate 1penpulimab 1human papillomavirus vaccine, L1 type 16, 18 1gimeracil 1apatinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Toremifene 1Tegafur 1Robotic Surgical Procedures 1Rifampin 1RAD140 1Pregnancy Tests 1Pemetrexed 1ON 01910 1Nivolumab 1Itraconazole 1Irinotecan 1Injections 1Infusions, Intravenous 1Hysterectomy 1Human Papillomavirus DNA Tests 1High-Intensity Focused Ultrasound Ablation 1Excipients 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × penpulimab × Other neoplasm × Clear all
NCT06297642 2024-08-06

TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Terminated
3 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡